CORDIS · 802878 · H2020
FunDiT Functional Diversity of T cells
Coordinator: USTAV MOLEKULARNI GENETIKY AV CR V.V.I. (CZ)
T cells have a central role in most adaptive immune responses, including immunity to infection, cancer, and autoimmunity. Increasing evidence shows that even resting steady-state T cells form many different subsets with unique functions. Variable level of self-reactivity and previous antigenic exposure are most likely two major determinants of the T-cell diversity. However, the number, identity, and biological function of steady-state T-cell subsets are still very incompletely understood. Receptors to ligands from TNF and B7 families exhibit variable expression among T-cell subsets and are im…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €1.7M awarded to the consortium. The project runs over approximately 5 years from 2019-01-01 to 2023-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from CZ
see all →- ESPOSA — Efficient Systems and Propulsion for Small Aircraft284859 · FP7 · €25.0M
- IMPULSE — Integrated Management and reliable oPerations for User-based Laser Scientific Excellence871161 · H2020 · €20.0M
- RICAIP — Research and Innovation Centre on Advanced Industrial Production857306 · H2020 · €15.0M
- FATRESCON — Concrete matrices for high-cycle-fatigue resistant, eco-efficient infrastructure101167045 · HORIZON · €10.0M
- CLOSER — Party Systems and Social Cleavages in the Post-Ottoman Space of the MENA Region101224232 · HORIZON · €9.8M
- 3Stops2Go — THREE STOP CODONS TO GET OVER TO FLOURISH101224040 · HORIZON · €9.8M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-STG funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.7M toward a total project budget of €1.7M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2018-STG.
- Who coordinates the project?
- The project is coordinated by USTAV MOLEKULARNI GENETIKY AV CR V.V.I. (CZ).
- What is the project timeline?
- The project runs from 2019-01-01 to 2023-12-31 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 802878.